Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 23, 2018EpilepsiaOpen Access

Long‐term cannabidiol treatment in patients with Dravet syndrome: An open‐label extension trial

View Full Paper
Ask AI
Bookmark
Share

Authors

ODOrrin DevinskyRNRima NabboutIMIan Miller

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Devinsky et al. (2018) studied this question.

synapsesocial.com/papers/6aa93f40f486d0383d25561fhttps://doi.org/10.1111/epi.14628
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Mortality in Dravet syndrome: A review2016 · 189 citations
  2. 2Inhibition of an equilibrative nucleoside transporter by cannabidiol: A mechanism of cannabinoid immunosuppression2006 · 501 citations
  3. 3Cannabidiol: Pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders2014 · 1,007 citations
  4. 4Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome2017 · 1,704 citations
  5. 5Treatment of Dravet Syndrome2016 · 117 citations